These studies indicate that IL-33 may be at least partly responsible for an induced immune-shift from Th1 to Th2 response and suppressing the Th17 immune response to exert anti-inflammatory effects and reduce cognitive impairment after CNS injury. The gene discussed is IL33; the disease is Cognitive impairment.